Literature DB >> 31859072

The prognostic nutritional index and postoperative complications after curative lung cancer resection: A retrospective cohort study.

Sukhee Park1, Hyun Joo Ahn2, Mikyung Yang3, Jie Ae Kim3, Jin Kyoung Kim3, Soo Jung Park3.   

Abstract

OBJECTIVE: The prognostic nutritional index is a score that represents a patient's immune-nutritional status based on the lymphocyte count and serum albumin concentration. We hypothesized that preoperative prognostic nutritional index is associated with postoperative complications and long-term outcomes after curative resection of lung cancer.
METHODS: We retrospectively analyzed 1011 patients with pathologic stage I-III adenocarcinoma and squamous cell carcinoma who underwent open thoracotomy for curative resection of lung cancer. The preoperative prognostic nutritional index was calculated as follows based on preoperative laboratory data: 10 × serum albumin (g/dL) + 5 × total lymphocyte count (/nL). The cutoff value of prognostic nutritional index (cutoff value: 50) was obtained by receiver operating characteristics curve and patients were classified as high and low groups. Outcomes were compared with the use of propensity scores and inverse probability weighting adjustment to reduce treatment selection bias.
RESULTS: The low group exhibited more postoperative complications (34% [96/285] vs 24% [174/726]; P = .002) especially pneumonia (13% [36/285] vs 6% [41/756]; P < .001) and delirium (10% [29/285] vs 5% [36/726]; P = .002), and greater in-hospital mortality (4% [11/285] vs 1% [9/726]; P = .007) than the high group. A low prognostic nutritional index was associated with greater postoperative pulmonary complications [odds ratio, 1.7; 95% confidence interval, 1.3-2.3], lower recurrence-free survival (hazard ratio, 1.3; 95% confidence interval, 1.1-1.5), and overall survival (hazard ratio, 1.5; 95% confidence interval, 1.2-1.8) after balancing the covariables.
CONCLUSIONS: The preoperative prognostic nutritional index was associated with postoperative pulmonary complications and long-term outcomes after curative resection of non-small cell lung cancer.
Copyright © 2019 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  pneumonia; postoperative complications; prognostic nutritional index; recurrence; thoracic surgery

Mesh:

Year:  2019        PMID: 31859072     DOI: 10.1016/j.jtcvs.2019.10.105

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  5 in total

1.  The Role of Cancer-Elicited Inflammatory Biomarkers in Predicting Early Recurrence Within Stage II-III Colorectal Cancer Patients After Curable Resection.

Authors:  Hou-Qun Ying; Yu-Cui Liao; Fan Sun; Hong-Xin Peng; Xue-Xin Cheng
Journal:  J Inflamm Res       Date:  2021-01-18

2.  Prognostic Nutritional Index identifies risk of early progression and survival outcomes in Advanced Non-small Cell Lung Cancer patients treated with PD-1 inhibitors.

Authors:  Na Liu; Aimin Jiang; Xiaoqiang Zheng; Xiao Fu; Haoran Zheng; Huan Gao; Jingjing Wang; Xuan Liang; Tao Tian; Zhiping Ruan; Yu Yao
Journal:  J Cancer       Date:  2021-03-15       Impact factor: 4.207

3.  Vasoactive inotropic score as a predictor of long-term mortality in patients after off-pump coronary artery bypass grafting.

Authors:  Ji-Hye Kwon; Seung Yeon Yoo; Seonwoo Kim; Hojeong Won; Wooksung Kim; Sukyoung Her; Yu Jeong Bang; Jungchan Park; Jong-Hwan Lee; Hyun Sung Cho; Jeong-Jin Min
Journal:  Sci Rep       Date:  2022-07-27       Impact factor: 4.996

4.  Prognostic Nutritional Index as a Novel Predictor of Long-Term Prognosis in Patients with Coronary Artery Disease After Percutaneous Coronary Intervention.

Authors:  Tian-Ding Liu; Ying-Ying Zheng; Jun-Nan Tang; Wei Wang; Xin-Ya Dai; Jian-Chao Zhang; Qian-Qian Guo; Meng-Die Cheng; Feng-Hua Song; Lei Fan; Zhi-Yu Liu; Zeng-Lei Zhang; Yan Bai; Kai Wang; Xiao-Ting Yue; Ru-Jie Zheng; Jin-Ying Zhang
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 3.512

5.  The advanced lung cancer inflammation index is the optimal inflammatory biomarker of overall survival in patients with lung cancer.

Authors:  Mengmeng Song; Qi Zhang; Chunhua Song; Tong Liu; Xi Zhang; Guotian Ruan; Meng Tang; Hailun Xie; Heyang Zhang; Yizhong Ge; Xiangrui Li; Kangping Zhang; Ming Yang; Qinqin Li; Xiaoyue Liu; Shiqi Lin; Yu Xu; Hongxia Xu; Kunhua Wang; Wei Li; Hanping Shi
Journal:  J Cachexia Sarcopenia Muscle       Date:  2022-07-14       Impact factor: 12.063

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.